ANDA 213730

NOVITIUM PHARMA

FDA Drug Application

Application #213730

Application Sponsors

ANDA 213730

NOVITIUM PHARMA

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003

Application Products

001	TABLET;ORAL	3.75MG	0	CLORAZEPATE DIPOTASSIUM	CLORAZEPATE DIPOTASSIUM
002	TABLET;ORAL	7.5MG	0	CLORAZEPATE DIPOTASSIUM	CLORAZEPATE DIPOTASSIUM
003	TABLET;ORAL	15MG	0	CLORAZEPATE DIPOTASSIUM	CLORAZEPATE DIPOTASSIUM

FDA Submissions

UNKNOWN;

ORIG

1

AP

2022-06-16

STANDARD

Submissions Property Types

ORIG

1

Null

15

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB

CDER Filings

Accessdata Error

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213730
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)